Establishment of insulin-resistant HepG2 cell model and pharmacological evaluation of pioglitazone

Chinese Pharmacological Bulletin

Volumn 22, Issue 2, 2006, Pages 248-251

  Chen, Qiu ^a   Xia, Yong Peng ^b   Qiu, Zong Yin ^b  

^a THE AFFILIATED HOSPITAL OF SOUTHWEST MEDICAL UNIVERSITY   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Cell model; Evaluation; HepG2 cell line; Insulin resistance; Pioglitazone

Indexed keywords

PIOGLITAZONE;

ARTICLE; CELL STRAIN HEPG2; CONTROLLED STUDY; DRUG EFFECT; GLUCOSE INTAKE; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; IN VITRO STUDY; INSULIN RESISTANCE; INSULIN SENSITIVITY;

EID: 33646245441     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Gurnell M, Savage DB, Chatterjee VK et al. The metabolic syndrome: Peroxisome proliferator-activated receptor gamma and its therapeutic modulation[J]. J Clin Endocrinol Metab, 2003, 88(6):2412-21.
2. Tadayyon M, Smith SA. Insulin sensitisation in the treatment of Type diabetes[J]. Expert Opin Investig Drags, 2003, 12(3):307 -24.
3. Melin B, Cherqui G, Blivet MJ et al. Dual effect of metformin in cultured rat hepatocytes: potentiation of insulin action and prevention of insulin-induced insulin resistance[J]. Metabolism, 1990, 39:1089.
4. Arakawa K, Ishihara T, Auto M et al. Action of novel antidiabetic thiazolidinedione, T-174, in animals of non-insulin-dependent diabetes mellitus (NIDDM) and in cultured muscle cells[J]. Br J Pharmacol, 1998, 125:429-36.
5. Senn JJ, Klover PJ, Nowak IA et al. Interleukin-6 induces cellular insulin resistance in hepatocytes[J]. Diabetes, 2002, 51(12):3391-9
6. Bernal MC, Weng S, Finck BN et al. Dexamethasone induction of hypertension and diabetes is PPAR - alpha dependent in LDL receptor-null mice[J]. Nat Med, 2003, 9(8):1069-75.
7. Camp HS. Thiazolidinediones in diabetes: Current status and future outlook[J]. Curr Opin Investig Drugs, 2003, 4(4):406-11.
8. Santure M, Pitre M, Nadeau A et al. Effect of troglitazone on vascular and glucose metabolic actions of insulin in high-sucrose-fed rats[J]. Metabolism, 2003, 52(8):978-86.
9. Julia A, Barman B, Greg L. Rosiglitazone[J]. Drugs, 1999, 57:921-7.